Miller Mary
Chief Legal Officer
Miller Mary has filed 10 SEC Form 4 filings (10 transaction rows) across 1 company, with disclosures dating back to 2025. 10 of those filings fall inside the rolling window. Most recent filing: Aug 20, 2026.
On the most recent filing, Miller Mary is listed as Chief Legal Officer at Acrivon Therapeutics, Inc. Inside the rolling window, Miller Mary reported no open-market purchases and 2 open-market sales totaling $1K in ACRV. The largest disclosed transaction in the window is a sale of 573 ACRV shares on Jul 21, 2026, worth $1K.
Companies traded
Other insiders at ACRV
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$1K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Miller Mary made?
Miller Mary has filed 10 SEC Form 4 filings (10 transaction rows) across 1 company since 2025.
Which companies does Miller Mary trade?
Miller Mary has filed SEC Form 4 disclosures for 1 company, including ACRV.
When was Miller Mary's most recent SEC Form 4 filing?
Miller Mary's most recent SEC Form 4 filing on Tracefour is dated Aug 20, 2026.
What is Miller Mary's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Miller Mary is listed as Chief Legal Officer.
What is Miller Mary's total buy and sell value in the current window?
Inside the rolling retention window, Miller Mary bought $0 and sold $1K based on SEC Form 4 filings.
What was Miller Mary's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 573 ACRV shares on 2026-07-21, worth $1K, per SEC Form 4 filings.